EverCommerce在AI工具和强劲的经常性收入的驱动下,在2025年第4季度,EverCommerce击败了收入和EBITDA预测,同时维持了2026年的指导,并启动了3 000万元股票回购。 EverCommerce beat revenue and EBITDA forecasts in Q4 2025, driven by AI tools and strong recurring revenue, while maintaining 2026 guidance and launching a $300M share buyback.

EverCommerce报告2025年第四季度收入为1.512亿美元，同比增长5.2%，调整后EBITDA为4420万美元，超出指引水平。 EverCommerce reported Q4 2025 revenue of $151.2 million, a 5.2% year-over-year increase, and adjusted EBITDA of $44.2 million, exceeding guidance. 该公司在经常性收入和交易量方面表现强劲,由AI驱动的保健工具,如EverHealth Scribe,显示客户满意度高,业务节约高。 The company achieved strong performance in recurring revenue and transaction volume, with AI-driven healthcare tools like EverHealth Scribe showing high customer satisfaction and operational savings. 尽管每股收入略有减少,但管理层维持了2026年的收入指导,在6.12亿至6.32亿美元之间,重点是AI整合和有纪律的资本分配,包括3亿美元的股份回购方案。 Despite a slight miss on earnings per share, management maintained 2026 revenue guidance between $612 million and $632 million, with a focus on AI integration and disciplined capital allocation, including a $300 million share repurchase program.